MAP2K7 and glioblastoma: Intrigued, we used a second inhibitor, U0126, which blocks MEK, as the MEK/ERK signaling cascade also plays an important role in GBM [32], where its activity is often intrinsically linked to PI3K-mediated signaling (e.g. [33–36]).